Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy.

× No keyword cloud information.

9 in total

Review 1. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature.

Authors: R L Rabin; A I Levinson
Journal: Clin Exp Immunol Date: 2008-05-26 Impact factor: 4.330

2. Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.

Authors: Ditina Desai; Raphaela Goldbach-Mansky; Joshua D Milner; Ronald L Rabin; Keith Hull; Frank Pucino; Nona Colburn
Journal: Ann Pharmacother Date: 2009-05 Impact factor: 3.154

Review 3. Immunologic, microbial, and epithelial interactions in atopic dermatitis.

Authors: Patrick M Brunner; Donald Y M Leung; Emma Guttman-Yassky
Journal: Ann Allergy Asthma Immunol Date: 2017-11-07 Impact factor: 6.347

Review 4. Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors: Brian A Baldo
Journal: Drug Saf Date: 2015-05 Impact factor: 5.228

5. Minimal-change disease secondary to etanercept.

Authors: Mariko Koya; Raimund Pichler; J Ashley Jefferson
Journal: Clin Kidney J Date: 2012-08-16

Review 6. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.

Authors: Yael Renert-Yuval; Emma Guttman-Yassky
Journal: Adv Ther Date: 2017-06-23 Impact factor: 3.845

7. Tumor Necrosis Factor Inhibitor-Induced Eczematous Eruption: A Report of Two Cases and Review of the Literature.

Authors: Sohemi Pagan-Leon; Tyler Werbel; Marjorie Montanez-Wiscovich
Journal: Cureus Date: 2021-05-17

Review 8. Biological Treatments in Atopic Dermatitis.

Authors: Andrea Montes-Torres; Mar Llamas-Velasco; Alejandra Pérez-Plaza; Guillermo Solano-López; Javier Sánchez-Pérez
Journal: J Clin Med Date: 2015-04-03 Impact factor: 4.241

9. Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis.

Authors: Savas Yayli; Nathalie Irla; Nikhil Yawalkar
Journal: Case Rep Dermatol Date: 2013-11-14

9 in total